INBX
Inhibrx Biosciences, Inc.
+4.25 (+4.18%)106.02USD85.5K成交股數1.6B市值–本益比(近四季)1200.3股價營收比-100.0%營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | – | 0 | 0-100% | 1.3M | 0 | 0-100% | 100K+233% | 0 | – | 119K | 30K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 23.9M | 25.2M | 25.3M | 28.5M | 22.3M | 36.9M | 38.9M | 67.6M | 63.9M | – | 38.1M | 34.1M |
| 銷售管理費用 | 8.3M | 5.7M | 5.6M | 5.3M | 6.4M | 6.0M | 7.9M | 93.4M | 10.0M | – | 7.9M | 7.3M |
| 營業利益 | −32.1M+17% | −30.9M-28% | −30.9M-34% | −33.8M-79% | −27.4M-63% | −42.9M | −46.8M+2% | −161M+289% | −73.8M | – | −45.8M | −41.3M |
| 營業利益率 | – | – | – | – | -2,106.8% | – | – | -160,898.0% | – | – | -38,510.1% | -137,796.7% |
| 稅後淨利 | −36.7M+28% | −33.4M-23% | −32.8M-25% | −35.3M-102% | −28.7M-64% | −43.3M-54% | −43.9M-15% | 1.9B-4049% | −78.7M | −93.6M | −51.8M | −47.1M |
| 淨利率 | – | – | – | – | -2,204.2% | – | – | 1,858,011.0% | – | – | -43,520.2% | -156,840.0% |
| 稀釋 EPS | -2.34+26% | -2.15-23% | -2.11-26% | -2.28-102% | -1.85-68% | -2.80 | -2.84-35% | 125.48-3011% | -5.77 | – | -4.39 | -4.31 |
| 稀釋股數 | 15.7M | 15.6M | 15.5M | 15.5M | 15.5M | 15.5M | 15.5M | 14.8M | 13.6M | 11.8M | 11.8M | 10.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 133M | 162M | 124M | 153M | 187M | 217M | 196M | 227M | 252M | 278M | 337M | 192M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 154M | 184M | 146M | 177M | 212M | 243M | 223M | 258M | – | 308M | – | – |
| 有息負債 | 176M | 175M | 101M | 99.9M | 99.3M | 98.7M | 0 | 0 | – | 207M | – | – |
| 總負債 | 207M | 205M | 138M | 141M | 144M | 148M | 44.1M | 39.1M | – | 264M | – | – |
| 股東權益 | −53.0M | −21.0M | 8.0M | 36.8M | 68.6M | 94.4M | 178M | 219M | 11.6M | 43.5M | 130M | −24.8M |
| 負債比 | 134.4% | 111.4% | 94.5% | 79.2% | 67.7% | 61.1% | 19.8% | 15.1% | – | 85.9% | – | – |
| 淨現金(現金 − 有息負債) | −42.9M | −13.3M | 23.7M | 53.2M | 87.3M | 118M | 196M | 227M | – | 71.0M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −38.0M+6% | – | – | – | −35.9M | – | – | −63.1M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 21K | – | – | 1.1M | – | – | – |
| 自由現金流 | – | −38.0M+6% | – | – | – | −35.9M | – | – | −64.2M | – | – | – |
| 折舊攤銷 | 523K | 537K | 564K | 582K | 662K | 675K | 760K | 475K | 360K | – | 304K | 295K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.3M
| Reportable | 1.3M | 100.0% | +550.0% |
|---|
產品／服務2025 年度 · 2.6M
| License | 1.3M | 50.0% | +550.0% |
|---|---|---|---|
| License Non Affiliate | 1.3M | 50.0% | +550.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.3M | +550.0% | −140M | -10,773.5% | -9.04 | −130M |
| FY2024 | 200K | -88.9% | 1.7B | 843,786.0% | 112.62 | −197M |
| FY2023 | 1.8M | – | −241M | -13,408.9% | -20.48 | −198M |